SEGMENT INFORMATION - Segment Information Of Net Sales And Operating Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Segment Reporting Information [Line Items]
Net sales	$ 2,810	$ 2,694	$ 5,435	$ 5,184
Cost of sales	1,819	1,663	3,583	3,192
Selling, general and administrative expenses	718	723	1,421	1,452
Research and development expenses	134	130	274	250
Segment operating income	191	179	249	294
Operating Segments | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	1,320	1,322	2,582	2,551
Cost of sales	755	734	1,449	1,402
Selling, general and administrative expenses	295	293	581	577
Research and development expenses	63	55	122	107
Other segment items	(32)	2	(53)	0
Segment operating income	239	238	483	465
Operating Segments | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	767	748	1,471	1,415
Cost of sales	388	380	744	726
Selling, general and administrative expenses	222	202	439	409
Research and development expenses	49	46	94	93
Other segment items	(10)	0	(17)	0
Segment operating income	118	120	211	187
Operating Segments | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	612	602	1,193	1,180
Cost of sales	428	407	824	789
Selling, general and administrative expenses	106	98	209	194
Research and development expenses	25	22	51	44
Other segment items	(11)	0	(18)	0
Segment operating income	$ 64	$ 75	$ 127	$ 153